Activation of growth factor receptors in esophageal cancer--implications for therapy.
Esophageal cancer is a highly aggressive disease and is the seventh most common cause of cancer-related death in the western world. Worldwide, it ranks as the sixth most frequent cause of cancer death. Despite advances in surgical techniques and treatment, the prognosis of esophageal cancer remains poor, with very few long-term survivors. The need for novel strategies to detect esophageal cancer earlier and to improve current therapy is urgent. It is well established that growth factors and growth factor receptor-mediated signaling pathways are important components of the transformation process in many forms of cancer, including esophageal cancer. With the recent advances in drug development, there are emerging possibilities to use growth factor signal transduction pathways in targeted therapy. This review provides a summary of the role of growth factors and their receptors in esophageal cancer and discusses their potential roles as biomarkers and as targets in therapy.
Ekman
Simon
S
Department of Oncology, University Hospital, Uppsala, Sweden. Simon.Ekman@onkologi.uu.se
Bergqvist
Michael
M
Heldin
Carl-Henrik
CH
Lennartsson
Johan
J
D000230:Adenocarcinoma / Q000378:metabolism* / Q000628:therapy; D004938:Esophageal Neoplasms / Q000378:metabolism* / Q000628:therapy; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology; D017978:Receptors, Growth Factor / Q000378:metabolism*; D015398:Signal Transduction
D036341:Intercellular Signaling Peptides and Proteins; D017978:Receptors, Growth Factor